Efficacy and safety of simple analgesics for acute treatment of episodic tension-type headache in adults: a network meta-analysis.

OBJECTIVE: Tension-type headache is the most common type of primary headache and results in a huge socioeconomic burden. This network meta-analysis (NMA) aimed to compare the efficacy and safety of simple analgesics for the treatment of episodic tension-type headache (ETTH) in adults. METHODS: We searched the Cochrane Library, PubMed, Web of Science, Embase, Chinese BioMedical Literature database and International Clinical Trials Registry Platform databases for eligible randomized clinical trials reporting the efficacy and/or safety of simple analgesics. A Bayesian NMA was performed to compare relative efficacy and safety. The surface under the cumulative ranking curve (SUCRA) was calculated to rank interventions. PROSPERO registration number: CRD42018090554. RESULTS: We highlighted six studies including 3507 patients. For the 2 h pain-free rate, the SUCRA ranking was ibuprofen > diclofenac-K > ketoprofen > acetaminophen > naproxen > placebo. All drugs except naproxen reported a higher 2 h pain-free rate than placebo, with a risk ratio (RR) of 2.86 (95% credible interval, CrI: 1.62-5.42) for ibuprofen and 2.61 (1.53-4.88) for diclofenac-K. For adverse events rate, the SUCRA ranking was: metamizol > diclofenac-K > ibuprofen > lumiracoxib > placebo > aspirin > acetaminophen > naproxen > ketoprofen. The adverse event rates of all analgesics were no higher than those of placebo, except for ketoprofen. Moreover, all drugs were superior to placebo in the global assessment of efficacy. In particular, the RR of lumiracoxib was 2.47 (1.57-4.57). Global heterogeneity I2 between the studies was low. CONCLUSIONS: Simple analgesics are considered more effective and safe as a placebo for ETTH in adults. Our results suggest that ibuprofen and diclofenac-K may be the two best treatment options for patients with ETTH from a comprehensive point of view (both high-quality evidence).

To our knowledge, this is the first network meta-analysis comparing the available data on adult patients with episodic tension-type headache (ETTH) treated with different simple analgesics recommended by the current guidelines.Ibuprofen (400 mg) and diclofenac-K (12.5 mg, 25 mg) are potentially the most effective and safe treatment options, supported by high-quality evidence.

Sb3+ Doping-Induced Triplet Self-Trapped Excitons Emission in Lead-Free Cs2SnCl6 Nanocrystals.

Doped halide perovskite nanocrystals (NCs) have opened new opportunities for the emerging optical and optoelectronic applications. Here, we describe a hot-injection synthesis of all-inorganic lead-free Cs2SnCl6 and Sb3+ doped Cs2SnCl6 NCs. Cs2SnCl6 NCs present a blue emission peak at 438 nm, whereas a new broad-band emission peak appears at 615 nm for the Sb3+ doped NCs. Comparative structural and spectral characterizations of Sb3+ doped Cs2SnCl6 NCs with micrometer-sized undoped and Sb3+ doped crystals show that the formation of broad-band orange emission is originted from triplet self-trapped excitons, attributed to the 3Pn-1S0 transitions (n = 0, 1, 2). Our results in Sb3+ doped Cs2SnCl6 materials provide insights into the machanisms of doping-induced emission centers, and it extends the existing knowledge of optical properties of doped halide NCs for further studies.